SPDR SSgA Global Allocat... Stock Quote GAL - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

44.7769

Bid

Ask

Volume

1,174

44.75 Day's Range 44.96

39.1526 52 Week Range 45.79

Market Cap

246.721M

Previous Close

45.00

Open

44.96

Last Trade

100

44.7769

Last Trade Time

Financial Volume

$ 52,585

VWAP

44.791

Average Volume (3m)

13,683

Shares Outstanding

5,510,000

Dividend Yield

PE Ratio

10.08

Earnings Per Share (EPS)

4.44

Revenue

6.83M

Net Profit

24.46M

The investment seeks to provide capital appreciation. The Adviser primarily invests the assets of the fund among exchange traded products (ETPs) that provide balanced exposure to domestic and international debt and equity securities. The fund typically allocates approximately 60% of its assets to eq... The investment seeks to provide capital appreciation. The Adviser primarily invests the assets of the fund among exchange traded products (ETPs) that provide balanced exposure to domestic and international debt and equity securities. The fund typically allocates approximately 60% of its assets to equity securities, though this percentage can vary based on the Advisers tactical decisions. Show more

Sector

Mgmt Invt Offices, Open-end

Industry

Mgmt Invt Offices, Open-end

Website

www.ssga.com

Headquarters

Boston, Massachusetts, USA

Founded

SPDR SSgA Global Allocation ETF is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker GAL. The last closing price for SPDR SSgA Global Allocat... was $45. Over the last year, SPDR SSgA Global Allocat... shares have traded in a share price range of $ 39.1526 to $ 45.79.

SPDR SSgA Global Allocat... currently has 5,510,000 shares outstanding. The market capitalization of SPDR SSgA Global Allocat... is $247.95 million. SPDR SSgA Global Allocat... has a price to earnings ratio (PE ratio) of 10.08.

Galantas Report Financial Results for the Quarter Ended June 30, 2024

TORONTO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) ("Galantas" or the "Company") is pleased to announce its unaudited financial results for...

Galantas Gold Announces Planned Solar Power Generation Facility at Omagh Gold Project, Northern Ireland

TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) is pleased to announce that it has agreed in principle to...

Galantas Gold Reports AGM Results

TORONTO, June 24, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) is pleased to report the results of its Annual and Special...

Galantas Gold Announces Completion of Trial Stoping Program at Omagh Gold Project, Northern Ireland

TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) is pleased to announce the successful completion of its...

Galantas Report Financial Results for the Quarter Ended March 31, 2024

TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (the ‘Company’) is pleased to announce its unaudited financial results for the Quarter ended March 31, 2024. Financial...

Galantas Gold Plans to Drill Key Target Area North of the Omagh Mine Site

TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) is pleased to announce plans to drill test the Kearney...

Galantas Gold Announces Convertible Debenture Conversion

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) announces that US$60,000 of convertible debentures, as...

Galantas Gold Grants Stock Options

TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) reports that it has awarded 3,175,000 incentive stock...

Galantas Report Annual Financial Results for the Year Ended December 31, 2023

TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (the ‘Company’) is pleased to announce its audited annual financial results for the year ended December 31, 2023. A copy of...

Galantas Gold Announces Geophysical Results for Key Exploration Target Area and Planning Approval for New Drilling Program at the Joshua Vein at Omagh Project

TORONTO, March 06, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) is pleased to announce the results of a recent gradient...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.8631	-1.89110429448	45.64	45.64	44.75	9929	45.34296	SP
4	-0.7831	-1.71883230904	45.56	45.7	44.5891	9681	45.14601973	SP
12	0.1269	0.284210526316	44.65	45.79	43.79	13683	45.18846512	SP
26	1.1869	2.7228722184	43.59	45.79	42.08	15194	44.27212962	SP
52	5.3769	13.6469543147	39.4	45.79	39.1526	15592	42.74478897	SP
156	-3.0231	-6.32447698745	47.8	47.8	35.5	18223	40.68037765	SP
260	5.6069	14.3142711259	39.17	48	29	17870	40.4124173	SP

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CEROCERo Therapeutics Holdings Inc	$ 0.2853 (52.40%)	1.15B
CYCNCyclerion Therapeutics Inc	$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	$ 1.2503 (41.60%)	164.49M
PULMPulmatrix Inc	$ 6.5586 (39.54%)	5.31M
ZTEKZentek Ltd	$ 1.2574 (29.96%)	308.63k
TFFPTFF Pharmaceuticals Inc	$ 0.376101 (-76.49%)	9.23M
EYENEyenovia Inc	$ 0.10185 (-70.05%)	51.98M
CTXRCitius Pharmaceuticals Inc	$ 0.1974 (-39.89%)	11.15M
VVPRVivoPower International PLC	$ 0.8151 (-39.62%)	2.3M
IPWiPower Inc	$ 0.7302 (-39.15%)	1.13M
CEROCERo Therapeutics Holdings Inc	$ 0.2853 (52.40%)	1.15B
ELABElevai Labs Inc	$ 0.0211 (-19.47%)	377.69M
NVDANVIDIA Corporation	$ 141.98 (-3.26%)	244.07M
SPPLSIMPPLE Ltd	$ 1.2503 (41.60%)	164.49M
STISolidion Technology Inc	$ 0.44 (25.71%)	139.46M